help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, H.
Right arrow Articles by Bai, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, H.
Right arrow Articles by Bai, W.
Molecular Endocrinology 14 (11): 1882-1896
Copyright © 2000 by The Endocrine Society

MEKK1 Activation of Human Estrogen Receptor {alpha} and Stimulation of the Agonistic Activity of 4-Hydroxytamoxifen in Endometrial and Ovarian Cancer Cells

Heehyoung Lee, Feng Jiang, Qiang Wang, Santo V. Nicosia, Jianhua Yang, Bing Su and Wenlong Bai

Department of Pathology (H.L., F.J., Q.W., S.V.N., W.B.) University of South Florida College of Medicine and H. Lee Moffitt Cancer Center Tampa, Florida 33612-4799
Department of Immunology (J.Y., B.S.) M. D. Anderson Cancer Center Houston, Texas 77030

Estrogens are mitogens that stimulate the growth of both normal and transformed epithelial cells of the female reproductive system. The effect of estrogens is mediated through the estrogen receptors, which are ligand-regulated transcription factors. Tamoxifen, a selective estrogen receptor modulator, functions as an estrogen receptor antagonist in breast but an agonist in uterus. In the current study, we show that coexpression of a constitutively active MEKK1, but not RAF or MEKK2, significantly increases the transcriptional activity of the receptor in endometrial and ovarian cancer cells. The expression of wild-type MEKK1 and an active Rac1, which functions upstream of MEKK1, also increased the activity of the receptor while coexpression of dominant negative MEKK1 blocked the Rac1 induction, indicating that endogenous MEKK1 is capable of activating the receptor. Additional experiments demonstrated that the MEKK1-induced activation was mediated through both Jun N-terminal kinases and p38/Hog1 and was independent of the known phosphorylation sites on the receptor. p38, but not Jun N-terminal kinases, efficiently phosphorylated the receptor in immunocomplex kinase assays, suggesting a differential involvement of the two kinases in the receptor activation. More importantly, the expression of the constitutively active MEKK1 increased the agonistic activity of 4-hydroxytamoxifen to a level comparable to that of 17ß-estradiol and fully blocked its antagonistic activity. These findings suggest that the uterine-specific agonistic activity of the tamoxifen compound may be determined by the status of kinases acting downstream of MEKK1.




This article has been cited by other articles:


Home page
 CarcinogenesisHome page
M. R. Bratton, D. E. Frigo, K. A. Vigh-Conrad, D. Fan, S. Wadsworth, J. A. McLachlan, and M. E. Burow
Organochlorine-mediated potentiation of the general coactivator p300 through p38 mitogen-activated protein kinase
Carcinogenesis, January 1, 2009; 30(1): 106 - 113.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. Mokhtari, J. W. Myers, and N. Welsh
The MAPK Kinase Kinase-1 Is Essential for Stress-Induced Pancreatic Islet Cell Death
Endocrinology, June 1, 2008; 149(6): 3046 - 3053.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Bao, C. Cao, X. Zhang, F. Jiang, S. V. Nicosia, and W. Bai
Suppression of {beta}-Amyloid Precursor Protein Signaling into the Nucleus by Estrogens Mediated through Complex Formation between the Estrogen Receptor and Fe65
Mol. Cell. Biol., February 15, 2007; 27(4): 1321 - 1333.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Q.-P. Li, X. Qi, R. Pramanik, N. M. Pohl, M. Loesch, and G. Chen
Stress-induced c-Jun-dependent Vitamin D Receptor (VDR) Activation Dissects the Non-classical VDR Pathway from the Classical VDR Activity
J. Biol. Chem., January 19, 2007; 282(3): 1544 - 1551.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
B. Liu, J.-f. Wu, Y.-y. Zhan, H.-z. Chen, X.-y. Zhang, and Q. Wu
Regulation of the Orphan Receptor TR3 Nuclear Functions by c-Jun N Terminal Kinase Phosphorylation
Endocrinology, January 1, 2007; 148(1): 34 - 44.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
T M Sadler, M Gavriil, T Annable, P Frost, L M Greenberger, and Y Zhang
Combination therapy for treating breast cancer using antiestrogen, ERA-923, and the mammalian target of rapamycin inhibitor, temsirolimus.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 863 - 873.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. V. Henley and K. S. Korach
Endocrine-Disrupting Chemicals Use Distinct Mechanisms of Action to Modulate Endocrine System Function
Endocrinology, June 1, 2006; 147(6): s25 - s32.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
D. E. Frigo, A. Basu, E. N. Nierth-Simpson, C. B. Weldon, C. M. Dugan, S. Elliott, B. M. Collins-Burow, V. A. Salvo, Y. Zhu, L. I. Melnik, et al.
p38 Mitogen-Activated Protein Kinase Stimulates Estrogen-Mediated Transcription and Proliferation through the Phosphorylation and Potentiation of the p160 Coactivator Glucocorticoid Receptor-Interacting Protein 1
Mol. Endocrinol., May 1, 2006; 20(5): 971 - 983.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Vivacqua, D. Bonofiglio, A. G. Recchia, A. M. Musti, D. Picard, S. Ando, and M. Maggiolini
The G Protein-Coupled Receptor GPR30 Mediates the Proliferative Effects Induced by 17{beta}-Estradiol and Hydroxytamoxifen in Endometrial Cancer Cells
Mol. Endocrinol., March 1, 2006; 20(3): 631 - 646.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
X. Cui, R. Schiff, G. Arpino, C. K. Osborne, and A. V. Lee
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
J. Clin. Oncol., October 20, 2005; 23(30): 7721 - 7735.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. C. Gutierrez, S. Detre, S. Johnston, S. K. Mohsin, J. Shou, D. C. Allred, R. Schiff, C. K. Osborne, and M. Dowsett
Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase
J. Clin. Oncol., April 10, 2005; 23(11): 2469 - 2476.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Y. M. Shah and B. G. Rowan
The Src Kinase Pathway Promotes Tamoxifen Agonist Action in Ishikawa Endometrial Cells through Phosphorylation-Dependent Stabilization of Estrogen Receptor {alpha} Promoter Interaction and Elevated Steroid Receptor Coactivator 1 Activity
Mol. Endocrinol., March 1, 2005; 19(3): 732 - 748.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. S. Jansen, S. C. Nagel, P. J. Miranda, E. K. Lobenhofer, C. A. Afshari, and D. P. McDonnell
Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition
PNAS, May 4, 2004; 101(18): 7199 - 7204.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Watanabe, H. Jono, J. Han, D. J. Lim, and J.-D. Li
Synergistic activation of NF-{kappa}B by nontypeable Haemophilus influenzae and tumor necrosis factor {alpha}
PNAS, March 9, 2004; 101(10): 3563 - 3568.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
H. Leong, J. E. Riby, G. L. Firestone, and L. F. Bjeldanes
Potent Ligand-Independent Estrogen Receptor Activation by 3,3'-Diindolylmethane Is Mediated by Cross Talk between the Protein Kinase A and Mitogen-Activated Protein Kinase Signaling Pathways
Mol. Endocrinol., February 1, 2004; 18(2): 291 - 302.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
S. K. Kolluri, N. Bruey-Sedano, X. Cao, B. Lin, F. Lin, Y.-H. Han, M. I. Dawson, and X.-k. Zhang
Mitogenic Effect of Orphan Receptor TR3 and Its Regulation by MEKK1 in Lung Cancer Cells
Mol. Cell. Biol., December 1, 2003; 23(23): 8651 - 8667.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A. Jones
Combining trastuzumab (Herceptin(R)) with hormonal therapy in breast cancer: what can be expected and why?
Ann. Onc., December 1, 2003; 14(12): 1697 - 1704.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Jiang, P. Li, A. J. Fornace Jr., S. V. Nicosia, and W. Bai
G2/M Arrest by 1,25-Dihydroxyvitamin D3 in Ovarian Cancer Cells Mediated through the Induction of GADD45 via an Exonic Enhancer
J. Biol. Chem., November 28, 2003; 278(48): 48030 - 48040.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
P. Li, H. Lee, S. Guo, T. G. Unterman, G. Jenster, and W. Bai
AKT-Independent Protection of Prostate Cancer Cells from Apoptosis Mediated through Complex Formation between the Androgen Receptor and FKHR
Mol. Cell. Biol., January 1, 2003; 23(1): 104 - 118.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
R. Schiff, S. Massarweh, J. Shou, and C. K. Osborne
Breast Cancer Endocrine Resistance: How Growth Factor Signaling and Estrogen Receptor Coregulators Modulate Response
Clin. Cancer Res., January 1, 2003; 9(1): 447s - 454s.
[Abstract] [Full Text]

Home page
 Mol. Cell. Biol.Home page
H. Lee and W. Bai
Regulation of Estrogen Receptor Nuclear Export by Ligand-Induced and p38-Mediated Receptor Phosphorylation
Mol. Cell. Biol., August 15, 2002; 22(16): 5835 - 5845.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. H. Driggers, J. H. Segars, and D. M. Rubino
The Proto-oncoprotein Brx Activates Estrogen Receptor beta by a p38 Mitogen-activated Protein Kinase Pathway
J. Biol. Chem., December 7, 2001; 276(50): 46792 - 46797.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. J. Ellis, A. Coop, B. Singh, L. Mauriac, A. Llombert-Cussac, F. Janicke, W. R. Miller, D. B. Evans, M. Dugan, C. Brady, et al.
Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1- and/or ErbB-2-Positive, Estrogen Receptor-Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial
J. Clin. Oncol., September 15, 2001; 19(18): 3808 - 3816.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
T. Shen, K. B. Horwitz, and C. A. Lange
Transcriptional Hyperactivity of Human Progesterone Receptors Is Coupled to Their Ligand-Dependent Down-Regulation by Mitogen-Activated Protein Kinase-Dependent Phosphorylation of Serine 294
Mol. Cell. Biol., September 15, 2001; 21(18): 6122 - 6131.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Sun, J. E. Paciga, R. I. Feldman, Z.-q. Yuan, D. Coppola, Y. Y. Lu, S. A. Shelley, S. V. Nicosia, and J. Q. Cheng
Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, Activated in Breast Cancer, Regulates and Is Induced by Estrogen Receptor {alpha} (ER{alpha}) via Interaction between ER{alpha} and PI3K
Cancer Res., August 1, 2001; 61(16): 5985 - 5991.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. Li, S. V. Nicosia, and W. Bai
Antagonism between PTEN/MMAC1/TEP-1 and Androgen Receptor in Growth and Apoptosis of Prostatic Cancer Cells
J. Biol. Chem., June 1, 2001; 276(23): 20444 - 20450.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society